Guizhou Long-Life Pharmaceutical

Guizhou Long-Life Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and Miao ethnomedicines. Established in 1996 and headquartered in Guiyang, Guizhou Province, the company is recognized as a national designated producer of ethnic medicines. It is currently a subsidiary of the Beijing Zhongzheng Wanrong Pharmaceutical Investment Group, following its acquisition and subsequent restructuring. The company's product portfolio includes unique formulations such as the Baicao Fuyanqing suppository, which utilizes a patented water-soluble technology for treating gynecological infections. Guizhou Long-Life maintains a strong research presence through collaborations with academic institutions to validate the efficacy and mechanisms of its herbal therapies. Its manufacturing facilities are GMP-certified and capable of producing various dosage forms, including suppositories, capsules, and granules.